Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Brain Lesion”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Not applicableLooking for participantsNCT06955832
What this trial is testing

Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI

Who this might be right for
Multiple Sclerosis
Benha University 30
Not applicableStudy completedNCT04220814
What this trial is testing

Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Rennes University Hospital 94
Not applicableStudy completedNCT00094068
What this trial is testing

The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
National Institutes of Health Clinical Center (CC) 76
Not applicableStudy completedNCT05426980
What this trial is testing

Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study

Who this might be right for
Multiple SclerosisMultiple Sclerosis LesionMultiple Sclerosis Brain Lesion
University of Ljubljana 654
Large-scale testing (Phase 3)Study completedNCT00799890
What this trial is testing

Sunphenon in Progressive Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Friedemann Paul 61
Testing effectiveness (Phase 2)Study completedNCT00676715
What this trial is testing

The Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genentech, Inc. 220
Testing effectiveness (Phase 2)Ended earlyNCT02038049
What this trial is testing

Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapse Remitting Multiple Sclerosis
Novartis Pharmaceuticals 8
Testing effectiveness (Phase 2)UnknownNCT03356769
What this trial is testing

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Who this might be right for
Tuberous Sclerosis ComplexAspirinEpilepsy+2 more
Peking Union Medical College Hospital 98
Post-approval studies (Phase 4)WithdrawnNCT00037115
What this trial is testing

Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.

Who this might be right for
Demyelinating DisordersMultiple SclerosisOptic Neuritis+2 more
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Large-scale testing (Phase 3)Study completedNCT03315923
What this trial is testing

Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients

Who this might be right for
Secondary Progressive Multiple Sclerosis
Isfahan University of Medical Sciences 84
Not applicableStudy completedNCT03268239
What this trial is testing

Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions

Who this might be right for
Magnetic Resonance ImagingCentral Nervous SystemBrain+2 more
Fondation Ophtalmologique Adolphe de Rothschild 180
Testing effectiveness (Phase 2)Looking for participantsNCT05359653
What this trial is testing

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Who this might be right for
Multiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+4 more
University of California, San Francisco 74
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06065670
What this trial is testing

Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Who this might be right for
Demyelinating DiseasesDemyelination; Corpus CallosumMultiple Sclerosis Brain Lesion+2 more
University of California, San Francisco 44
Not applicableStudy completedNCT04639401
What this trial is testing

Auditory-motor Coupling in Multiple Sclerosis With Cerebellar Lesions

Who this might be right for
Multiple SclerosisCerebral Lesion
Hasselt University 8
Not applicableStudy completedNCT05718947
What this trial is testing

Ultra-high-field Brain MRI in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Zuyderland Medisch Centrum 10
Not applicableStudy completedNCT06789419
What this trial is testing

Predicting Epileptogenic Tubers in Patients with Tuberous Sclerosis Complex

Who this might be right for
Tuberous Sclerosis Complex
Beijing Children's Hospital 112
Not applicableEnded earlyNCT02967380
What this trial is testing

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Who this might be right for
Adult Anaplastic (Malignant) MeningiomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+22 more
University of Southern California 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT04742400
What this trial is testing

Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 12
Not applicableWithdrawnNCT04344626
What this trial is testing

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Who this might be right for
EpilepsyFocal Cortical DysplasiaTuberous Sclerosis+7 more
University of California, Los Angeles
Not applicableStudy completedNCT00617383
What this trial is testing

AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
The University of Texas Health Science Center, Houston 3
Load More Results